The new plan to reform European Union pharmaceutical legislation falls short on data and market protections but includes positive efforts to streamline drug approval …
Plan to reform EU pharma law elicits kudos and concerns from BIO experts Read More »
Despite progress from some U.S. trading partners in developing global intellectual property protections that enable innovation, much improvement is needed, according to the Special …
USTR calls out countries needing better IP protections in annual report Read More »
Ordinary market mechanisms are inadequate against the emerging public health threat of antimicrobial resistance (AMR), lawmakers and experts agreed at the April 28 hearing …
Hearing on public health threat from AMR puts spotlight on PASTEUR Act Read More »
Major leisure-wear label lululemon is now selling men’s and women’s shirts made from Geno’s plant-based nylon, which looks and feels like traditional nylon but …
Geno’s plant-based nylon hits global market in lululemon’s new shirt line Read More »
The pace of biotech investment has slowed recently, harming development at the small, new companies that are driving innovation. “Coming down from the heyday …
BIO webinar will advise biotech on weathering the slowing investor market Read More »
While animal activists oppose animal testing on moral grounds, the biotech industry knows that alternative technology can provide more accurate and less expensive screening …
Biotech wants to reduce animal testing and FDA is now tasked with helping Read More »
When it comes to long COVID, health care providers and the biotech industry must be aware of what is already known, but we still …
BIO’s long COVID webinar furthers search for biotech solutions Read More »
While research into long COVID-19 is offering clues to causes and potential targets for treatment, defeating this debilitating condition, which impacts millions, requires a …
BIO’s online conference invites biotech to join in fighting long COVID Read More »
Rachel King, Interim CEO of the Biotechnology Innovation Organization (BIO), described the organization’s work and goals for 2023 at the Maryland Tech Council (MTC)’s …
BIO’s Interim CEO discusses biotech policy, optimism with industry in Maryland Read More »
When the largest private insurance companies use their leverage to save on the cost of prescription drugs, they make it harder for patients to …
Excluding drugs from coverage helps PBMs keep profits higher Read More »
